If you have pancreatic cancer and surgery is not an option, consider a new clinical research trial that is delivering chemotherapy in a new way.
The trial combines the benefits of standard-of-care therapy with a targeted treatment approach to reach more tumor cells.1
Patients will receive chemotherapy in 2 ways:
Systemic infusion is an important part of treatment, but due to the tumor's dense structure and poor blood flow, therapy doesn't always get into the tumor.2 Direct infusion with the PEDD approach with SmartValve technology is designed to overcome those barriers.
This new approach aims to reduce the number and size of tumors and keep the disease stable for longer.1,3
Watch an informational video about our clinical trial
Fight with everything you can • Access an entirely new approach • Join a breakthrough clinical trial
Clinical research trials are a way for you to gain every advantage
If you or someone you know has locally advanced, metastatic pancreatic cancer that cannot be treated with surgery and is between 18-80 years of age, consider participating in the following study: Pressure-Enabled Drug Delivery™ (PEDD™) by Retrograde Venous Infusion (RVI) for Advanced Pancreatic Carcinoma. This clinical research trial is designed to evaluate a new procedure for the administration of chemotherapy to patients with pancreatic cancer.
The technology being studied delivers established cancer therapies at increased pressure, which is designed to overcome the infusion barriers associated with the dense structure and poor vasculature of pancreatic tumors.
DOWNLOAD a patient brochure about the clinical research trial.
You may qualify for the PEDD Study if all of the following apply to you*:
Take advantage of an opportunity to get early-access pancreatic cancer treatments
The Pancreatic Cancer Action Network (pancan.org) offers several reasons to be a part of investigational research4:
If you qualify and decide to participate in the PEDD Study:
Join in. Be part of the medical research needed to advance care.
Others are here to support you in the fight against pancreatic cancer.